Latest Licensing News

New Hope Group exceeded its FY26 coal production and sales guidance, driven by strong performances at Bengalla and New Acland mines, alongside a notable price uplift amid global supply tightness.

Audinate Group Limited reported a 15% revenue increase driven by its expanding Dante ecosystem and Iris acquisition, but underlying EBITDA losses widened amid restructuring and investment costs.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Barramundi Limited’s portfolio delivered a 2.2% gross return in July, outpacing the S&P/ASX200 hedged benchmark, driven by strong performances in healthcare and financials alongside strategic portfolio adjustments.

Ainsworth Game Technology has locked in a critical patent licence agreement with Aristocrat, granting rights to key gaming features and responsible gaming technologies in Australia while settling past patent disputes.

Kincora Copper has accelerated exploration activities across its Australian portfolio, including partner-funded drilling with AngloGold Ashanti and sole-funded programs at Condobolin, while divesting its Mongolian assets for US$10 million to sharpen focus and strengthen its balance sheet.

Motio Limited delivered a robust FY26 with profit before tax rising to $1.622 million, underpinned by record revenue months and a strengthened balance sheet following a capital raise.

Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.

ADX Energy’s HOCH-1 well in Upper Austria shows promising gas flow and reservoir extent, with further multi-zone testing set to resume after delays.

Caravel Minerals has significantly advanced its Caravel Copper Project with a near-complete Definitive Feasibility Study, marked by a 48% increase in Proven Ore Reserves and strengthened funding arrangements.

FINEOS Corporation Holdings PLC reported a robust half with 7.9% total revenue growth, a 32% jump in EBITDA, and a return to net profit driven by subscription sales and operational efficiencies.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.